Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-21

Clinical Trial Update: Clopidogrel Monotherapy in Patients With High Bleeding Risk [Phase 4]

View source ↗

Summary

Phase 4 trial update on clopidogrel monotherapy in patients with high bleeding risk; results completed and posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Mayo Clinic | Conditions: Bleeding Complications | Phase 4 | Status: COMPLETED | Results posted: 2024-02-21